This is what you can expect to learn when you come to our Early Commercialisation, Lifecycle & Portfolio Managment congress:

You will learn to...

• Manage budgets by scrapping unpromising drug leads early through good decision making, communications and biomarkers
• Create the best teams to meet your companies strategic target, and work effectively and efficiently within cross functional teams
• Increase the speed and efficiency of the launch phase through excellent market intelligence, data gathering and accurate long-term forecasts
• Ensure great market access by engaging with key opinion leaders and stakeholders at the right time in the right manner
• Formulate the right risk-pricing strategies and reimbursement cases by utilising health outcomes and pharmacoeconomic data
• Extract every last Euro possible from your drugs by managing their lifecycle better; using and communicating their key strengths at the right time
• Align and improve local integration of global strategic planning for improved overall sales
• Defend your drugs against generic competition at the end of its lifecycle and manage its transition to over-the-counter status (depending on the drug and indication)

Event registration has now opened and the brochure is available to download.

To view the brochure, please click here!

Just come of our key speakers include:

For the full list, please download the brochure!